<VariationArchive RecordType="classified" VariationID="219383" VariationName="NM_017617.5(NOTCH1):c.6049_6050del (p.Ser2017fs)" VariationType="Deletion" Accession="VCV000219383" Version="1" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-03-26" DateCreated="2016-02-02" MostRecentSubmission="2016-02-02">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="221062" VariationID="219383">
      <GeneList>
        <Gene Symbol="NOTCH1" FullName="notch receptor 1" GeneID="4851" HGNC_ID="HGNC:7881" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>9q34.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="136494433" stop="136546048" display_start="136494433" display_stop="136546048" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="139388895" stop="139440237" display_start="139388895" display_stop="139440237" Strand="-" />
          </Location>
          <OMIM>190198</OMIM>
        </Gene>
        <Gene Symbol="LOC126860794" FullName="BRD4-independent group 4 enhancer GRCh37_chr9:139392592-139393791" GeneID="126860794" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>9q34.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="136498140" stop="136499339" display_start="136498140" display_stop="136499339" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_017617.5(NOTCH1):c.6049_6050del (p.Ser2017fs)</Name>
      <CanonicalSPDI>NC_000009.12:136499143:GAG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9q34.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="136499144" stop="136499145" display_start="136499144" display_stop="136499145" variantLength="2" positionVCF="136499143" referenceAlleleVCF="TGA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="139393596" stop="139393597" display_start="139393596" display_stop="139393597" variantLength="2" positionVCF="139393595" referenceAlleleVCF="TGA" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>S2017fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1122" sequenceAccession="LRG_1122" change="g.51642_51643del">
            <Expression>LRG_1122:g.51642_51643del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1122t1" sequenceAccession="LRG_1122t1" change="c.6049_6050del">
            <Expression>LRG_1122t1:c.6049_6050del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1122p1" sequenceAccession="LRG_1122p1" change="p.Ser2017fs">
            <Expression>LRG_1122p1:p.Ser2017fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.139393597_139393598del" Assembly="GRCh37">
            <Expression>NC_000009.11:g.139393597_139393598del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.136499145_136499146del" Assembly="GRCh38">
            <Expression>NC_000009.12:g.136499145_136499146del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007458.1" sequenceAccession="NG_007458" sequenceVersion="1" change="g.51642_51643del">
            <Expression>NG_007458.1:g.51642_51643del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_017617.5" sequenceAccession="NM_017617" sequenceVersion="5" change="c.6049_6050del" MANESelect="true">
            <Expression>NM_017617.5:c.6049_6050del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_060087.3" sequenceAccession="NP_060087" sequenceVersion="3" change="p.Ser2017fs">
            <Expression>NP_060087.3:p.Ser2017fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA350398" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="190198.0009" DB="OMIM" />
        <XRef Type="rs" ID="864622063" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_017617.5(NOTCH1):c.6049_6050del (p.Ser2017fs) AND Adams-Oliver syndrome 5" Accession="RCV000206353" Version="1">
        <ClassifiedConditionList TraitSetID="19567">
          <ClassifiedCondition DB="MedGen" ID="C4014970">Adams-Oliver syndrome 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2014-01-07" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2014-01-07" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2016-02-02" MostRecentSubmission="2016-02-02">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">1621771</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25963545</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="19567" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="31885" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Adams-Oliver syndrome 5</ElementValue>
                <XRef ID="MONDO:0014459" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AOS5</ElementValue>
                <XRef Type="MIM" ID="616028" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Adams-Oliver syndrome (AOS) is characterized by aplasia cutis congenita (ACC) of the scalp and terminal transverse limb defects (TTLD). ACC lesions usually occur in the midline of the parietal or occipital regions, but can also occur on the abdomen or limbs. At birth, an ACC lesion may already have the appearance of a healed scar. ACC lesions less than 5 cm often involve only the skin and almost always heal over a period of months; larger lesions are more likely to involve the skull and possibly the dura, and are at greater risk for complications, which can include infection, hemorrhage, or thrombosis, and can result in death. The limb defects range from mild (unilateral or bilateral short distal phalanges) to severe (complete absence of all toes or fingers, feet or hands, or more, often resembling an amputation). The lower extremities are almost always more severely affected than the upper extremities. Additional major features frequently include cardiovascular malformations/dysfunction (23%), brain anomalies, and less frequently renal, liver, and eye anomalies.</Attribute>
                <XRef ID="NBK355754" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27077170</ID>
                <ID Source="BookShelf">NBK355754</ID>
              </Citation>
              <XRef ID="974" DB="Orphanet" />
              <XRef ID="C4014970" DB="MedGen" />
              <XRef ID="MONDO:0014459" DB="MONDO" />
              <XRef Type="MIM" ID="616028" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="484169" SubmissionDate="2015-08-25" DateLastUpdated="2016-02-02" DateCreated="2016-02-02">
        <ClinVarSubmissionID localKey="NM_017617.3:c.6049_6050delTC|OMIM:616028" />
        <ClinVarAccession Accession="SCV000259217" DateUpdated="2016-02-02" DateCreated="2016-02-02" Type="SCV" Version="1" SubmitterName="Molecular and Medical Genetics Group, King's College London" OrgID="505685" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-01-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25963545</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Submitter's publication</Attribute>
          <Citation>
            <ID Source="PubMed">25963545</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NOTCH1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_017617.3:exon 32</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NP_060087.3:p.S2017Tfs*9</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_017617.3:c.6049_6050delTC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616028" Type="MIM" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">25963545</ID>
        </Citation>
      </ClinicalAssertion>
      <ClinicalAssertion ID="490855" SubmissionDate="2016-01-30" DateLastUpdated="2016-02-02" DateCreated="2016-02-02">
        <ClinVarSubmissionID localKey="190198.0009_ADAMS-OLIVER SYNDROME 5" title="NOTCH1, 2-BP DEL, 6049TC_ADAMS-OLIVER SYNDROME 5" />
        <ClinVarAccession Accession="SCV000262556" DateUpdated="2016-02-02" DateCreated="2016-02-02" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-01-30">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an Italian male proband with Adams-Oliver syndrome-5 (AOS5; 616028), originally reported by Dallapiccola et al. (1992), Southgate et al. (2015) identified heterozygosity for a 2-bp deletion (c.6049_6050delTC, NM_017617.3) in the NOTCH1 gene, causing a frameshift predicted to result in a premature termination codon (Ser2017ThrfsTer9) within the intracellular ANK repeat domain. DNA was unavailable from the proband's affected mother.</Attribute>
              <Citation>
                <ID Source="PubMed">1621771</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">25963545</ID>
              </Citation>
              <XRef DB="OMIM" ID="616028" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NOTCH1" />
          </GeneList>
          <Name>NOTCH1, 2-BP DEL, 6049TC</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 6049TC</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="190198.0009" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ADAMS-OLIVER SYNDROME 5</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="490855" TraitType="Disease" MappingType="Name" MappingValue="ADAMS-OLIVER SYNDROME 5" MappingRef="Preferred">
        <MedGen CUI="C4014970" Name="Adams-Oliver syndrome 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="484169" TraitType="Disease" MappingType="XRef" MappingValue="616028" MappingRef="OMIM">
        <MedGen CUI="C4014970" Name="Adams-Oliver syndrome 5" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

